NCT07891819

Brief Summary

This study evaluated acupuncture plus optimized conventional pharmacological treatment compared with optimized conventional pharmacological treatment alone for chronic pain in adults with chronic kidney disease receiving conservative treatment, peritoneal dialysis, or hemodialysis. The study was conducted prospectively at a single center. Actual allocation was not exclusively randomized because some participants who expressed a preference for acupuncture before allocation were assigned to the acupuncture group, while the planned random sequence was used for participants without an expressed preference.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable chronic-pain

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2026

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 23, 2026

Completed
Last Updated

October 23, 2026

Status Verified

October 1, 2026

Enrollment Period

2.5 years

First QC Date

October 9, 2026

Last Update Submit

October 17, 2026

Conditions

Keywords

AcupuncturehemodialysisPeritoneal dialysischronic kidney diseasepain management

Outcome Measures

Primary Outcomes (1)

  • Change in pain intensity from baseline to the final study visit

    Change in pain intensity from baseline to 5 months, measured using the 0-to-10 Visual Analog Scale (VAS) for pain, where 0 indicates no pain and 10 the worst imaginable pain. Higher scores indicate worse pain; a negative change indicates improvement.

    Baseline and 5 months

Secondary Outcomes (4)

  • Proportion of participants achieving a reduction of at least 2 points in pain intensity

    Baseline and 5 months

  • Change in limitation of daily activities

    Baseline to 5 months

  • Adverse events

    From baseline through 5 months

  • Change in SF-36 scores

    Baseline and 5 months

Study Arms (2)

Acupuncture plus conventional treatment - Experimental

EXPERIMENTAL

Individualized acupuncture administered weekly for approximately four months, with 16 sessions planned and a minimum of 10 sessions considered necessary for efficacy evaluation. Participants also received optimized conventional pharmacological treatment.

Other: AcupunctureDrug: Optimized conventional pharmacological treatment

Conventional treatment alone

ACTIVE COMPARATOR

Optimized conventional pharmacological treatment for chronic pain, without acupuncture.

Drug: Optimized conventional pharmacological treatment

Interventions

Individualized acupuncture administered weekly for approximately four months, with 16 sessions planned and a minimum of 10 sessions considered necessary for efficacy evaluation.

Acupuncture plus conventional treatment - Experimental

Conventional pharmacological treatment for chronic pain in patients with chronic kidney disease, individualized according to the treating physician's clinical judgment.

Acupuncture plus conventional treatment - ExperimentalConventional treatment alone

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 75 years, of either sex
  • Chronic pain lasting more than 3 months
  • Pain intensity of at least 6 on a 0-to-10 visual analog scale (VAS) at the allocation visit (V2)
  • Chronic kidney disease managed with conservative treatment or receiving renal replacement therapy with peritoneal dialysis or hemodialysis
  • Signed informed consent

You may not qualify if:

  • Pregnancy
  • Inability to understand study instructions, attend study visits, or complete the assessment scales
  • History of alcohol or drug abuse
  • Psychological or emotional disorders considered likely to invalidate informed consent or limit adherence to study procedures
  • Coagulation disorders
  • Allergy to commonly used analgesic medications
  • Recommendation to discontinue nonsteroidal anti-inflammatory drugs (NSAIDs)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital do Rim

São Paulo, São Paulo, 05078-000, Brazil

Location

MeSH Terms

Conditions

Chronic PainNeuralgiaRenal Insufficiency, ChronicAgnosia

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPerceptual DisordersNeurobehavioral Manifestations

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
The study was open-label. Participants and study personnel were aware of the treatment received. No masking was used.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The protocol planned simple 1:1 randomization using a computer-generated random sequence. Participants who expressed a preference for acupuncture before allocation and refused the possibility of receiving conventional pharmacological treatment alone were assigned to the acupuncture group regardless of the planned sequence. Participants without an expressed preference were allocated using the planned random sequence. Actual allocation was therefore not exclusively randomized.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 9, 2026

First Posted

October 23, 2026

Study Start

September 6, 2023

Primary Completion

February 17, 2026

Study Completion

February 17, 2026

Last Updated

October 23, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share

There is no current plan to share individual participant-level data.

Locations